Code Biotherapeutics snags $10m

Code Biotherapeutics Inc, a next-generation gene therapy company, has secured $10 million in financing.

Code Biotherapeutics Inc, a next-generation gene therapy company, has secured $10 million in financing. The lead backers were 4BIO Capital and UPMC Enterprises.

Source: Press Release